Drug Database
Back to search

Netherlands· NL-1307749ae1fb

Synarel, neusspray 200 microgram per dosis

A nafarelin product containing nafarelineacetaat, registered in Netherlands by Pfizer B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC H01CA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSynarel, neusspray 200 microgram per …ATCH01CA02REGISTER NO.NL-1307749ae1fbPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nafarelineacetaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nafarelin is registered in 12 of 19 countries.

Countries holding a registration under ATC H01CA02 (nafarelin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search nafarelin products by name

Nafarelin · ATC H01CA02

12 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NAFARELINEACETAAT
Manufacturer
Pfizer B.V.
Country
Netherlands (NL)
ATC code
H01CA02
ATC class
Nafarelin
Defined daily dose
0.4 mg, N
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    15086

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nafarelin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nafarelin products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Czechia · Synarel
  • Germany · Synarela
  • Denmark · Synarela
  • Spain · Synarel
  • Finland · Synarela
  • France · Synarel
  • United Kingdom (Northern Ireland) · Synarel
  • Ireland · Synarel
  • Iceland · Synarela
  • Norway · Synarela
  • Sweden · Synarela

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/77189b65-a60c-4efb-b4fc-6eb515899fc7
GET /v1/drugs/77189b65-a60c-4efb-b4fc-6eb515899fc7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Neusspray, oplossing",
  "route": "Nasaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15086_smpc.pdf",
  "strength": null,
  "atc_label": "Nafarelin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg15086",
  "excipients": [
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "BENZALKONIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "SORBITOL (E 420)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "NAFARELINEACETAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h15086.pdf",
  "authorised_at": "1991/10/14",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "15086",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about nafarelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console